IDEXX Laboratories Balance Sheet Health
Financial Health criteria checks 6/6
IDEXX Laboratories has a total shareholder equity of $1.5B and total debt of $947.9M, which brings its debt-to-equity ratio to 63.9%. Its total assets and total liabilities are $3.3B and $1.8B respectively. IDEXX Laboratories's EBIT is $1.1B making its interest coverage ratio 30.5. It has cash and short-term investments of $453.9M.
Key information
63.9%
Debt to equity ratio
US$947.88m
Debt
Interest coverage ratio | 30.5x |
Cash | US$453.93m |
Equity | US$1.48b |
Total liabilities | US$1.78b |
Total assets | US$3.26b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 0J8P's short term assets ($1.5B) exceed its short term liabilities ($951.5M).
Long Term Liabilities: 0J8P's short term assets ($1.5B) exceed its long term liabilities ($823.8M).
Debt to Equity History and Analysis
Debt Level: 0J8P's net debt to equity ratio (33.3%) is considered satisfactory.
Reducing Debt: 0J8P had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: 0J8P's debt is well covered by operating cash flow (95.6%).
Interest Coverage: 0J8P's interest payments on its debt are well covered by EBIT (30.5x coverage).